Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
Drugs. 2021 Nov;81(16):1859-1879. doi: 10.1007/s40265-021-01610-1. Epub 2021 Oct 27.
Drugs. 2021.
PMID: 34705255
Free PMC article.
Review.
Key considerations in the preclinical development of biosimilars.
Bui LA, Hurst S, Finch GL, Ingram B, Jacobs IA, Kirchhoff CF, Ng CK, Ryan AM.
Bui LA, et al. Among authors: ingram b.
Drug Discov Today. 2015 May;20 Suppl 1:3-15. doi: 10.1016/j.drudis.2015.03.011. Epub 2015 Apr 23.
Drug Discov Today. 2015.
PMID: 25912284
Review.
Item in Clipboard
Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities.
Ingram B, Lumsden RS, Radosavljevic A, Kobryn C.
Ingram B, et al.
Pharmaceuticals (Basel). 2021 Apr 1;14(4):306. doi: 10.3390/ph14040306.
Pharmaceuticals (Basel). 2021.
PMID: 33915725
Free PMC article.
Item in Clipboard
Cite
Cite